Indications
Adjunct to rest and physical therapy in the treatment of
muscle spasm associated with acute painful musculoskeletal
conditions.
Action
Skeletal muscle relaxation, probably due to CNS depression.
Therapeutic Effects: Skeletal muscle relaxation.
Pharmacokinetics
Absorption: Well absorbed after oral administration.
Distribution: Crosses the placenta; high concentrations
in breast milk.
Metabolism and Excretion: Mostly metabolized
by the liver via CYP2C19 to meprobamate; 2% of
Whites, 4% of Blacks, and 14% of Asians have CYP2C19
genotype that results in reduced metabolism of carisoprodol
(poor metabolizers) into its active metabolite
(may result inqsedation).
Half-life: 8 hr.
TIME/ACTION PROFILE (skeletal muscle
relaxation)
ROUTE ONSET PEAK DURATION
PO 30 min unknown 4–6 hr
Contraindications/Precautions
Contraindicated in: Hypersensitivity to carisoprodol
or to meprobamate; Porphyria or suspected porphyria.
Use Cautiously in: Severe liver or kidney disease;
OB, Lactation, Pedi: Safety not established for pregnant
women, breast feeding infants, or children 16 yr;
Geri: Poorly tolerated due to anticholinergic effects. Appears
on Beers list.
Adverse Reactions/Side Effects
CNS: dizziness, drowsiness, agitation, ataxia, depression,
headache, insomnia, irritability, syncope. Resp:
asthma attacks. CV: hypotension, tachycardia. GI: epigastric
distress, hiccups, nausea, vomiting. Derm:
flushing, rashes. Hemat: eosinophilia, leukopenia.
Misc: ANAPHYLACTIC SHOCK, fever, psychological dependence,
severe idiosyncratic reaction.
Interactions
Drug-Drug: Additive CNS depression with other CNS
depressants including alcohol, antihistamines,
opioid analgesics, and sedative/hypnotics.
Drug-Natural Products: Concomitant use of
kava-kava, valerian, skullcap, chamomile, or
hops canqCNS depression.
Route/Dosage
PO (Adults 16 yr): 250–350 mg 4 times daily for
no longer than 2–3 wk.
Availability (generic available)
Tablets: 250 mg, 350 mg. Cost: Generic—250 mg
$330.59/100, 350 mg $59.62/100. In combination
with: aspirin and codeine (generic only). See
Appendix B.
No comments:
Post a Comment